跳至主要内容
临床试验/NCT07425535
NCT07425535招募中早期 1 期

Optic Nerve Head Strain in Non-glaucoma Subjects

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年6月24日最近更新:
干预措施

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Optic nerve head strain

研究概览

简要总结

Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glaucoma injures the eye.

详细描述

The present proposal seeks to measure biomechanical strains in age-matched control subjects who do not have Open-angle Glaucoma (OAG), using the same non-invasive imaging methods as in the above programs. This is necessary as even undamaged OAG eyes may have different biomechanical properties at baseline than do non-OAG eyes. While there are some limited methods to test strains in control eyes, to compare normal to OAG responses robustly, the same methods of changing intra-ocular pressure (IOP) must be applied-namely to lower IOP by delivery of FDA-approved agent, latanoprost, as has been done in the investigator's OAG subjects. The method of measuring strain requires images taken at two different IOP levels.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Biostatistician

入排标准

年龄范围
30 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults who have no history of OAG
  • Have an ocular examination by a glaucoma specialist with no indications of OAG
  • Have normal optical coherence tomography findings in the retinal nerve fiber layer.
  • Over age 30 will be included from
  • Both sexes
  • All ethnic groups.
  • Optic neuropathy.
  • Both suspects and those with glaucoma damage will be included.
  • When both eyes meet inclusion and

排除标准

  • , both eyes will be included in the study and statistical methods will be used to account for correlations between eyes within the same individual.
  • Exclusion Criteria:
  • in whom sitting in an upright position is impossible due to physical disability
  • with ocular media opacity, corneal scarring, cataract or vitreous hemorrhage, that does not allow adequate imaging resolution.
  • in whom keeping the eyes open during the imaging procedure is not possible or uncomfortable.
  • who cannot perform home tonometry accurately at certification
  • who do not have reliable clinical Optical Coherence Tomography (OCT) testing.
  • with any form of glaucoma
  • with high myopia defined as refractive error > -8
  • with past keratorefractive surgery, corneal dystrophy, or corneal ectasia that would make self-tonometry measurements difficult to interpret
  • inability to understand English or with a language or hearing impairment

研究组 & 干预措施

Study group

Experimental

The participants will take an approved glaucoma eye drop, latanoprost, for less than one month, with pictures of the eyes at baseline and while taking the drop.

干预措施: Latanoprost (0.005%) (Drug)

结局指标

主要结局

Optic nerve head strain

时间窗: up to 1 month

Biomechanical strain measured by optical coherence tomography

次要结局

未报告次要终点

研究者

发起方
Johns Hopkins University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验